Risk factors for secondary skin cancer after blood or marrow transplant include those who had treatment with a monoclonal ...

PHILADELPHIA, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is ...

It is a useful therapy with several drawbacks that limit its effectiveness, including prolonged light sensitivity, poor ...

Analysts at Roth Capital issued their FY2028 earnings per share (EPS) estimates for shares of Sensus Healthcare in a research note issued to investors on Thursday, February 6th. Roth Capital analyst J ...

Jan. 27, 2025 — Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally advanced tumors in particular can be difficult to ...

T-VEC enables BCC resectability in 50% of cases, showing promise as a neoadjuvant therapy with mild side effects.

The clinical approach, epidemiology, diagnostic procedures, and management, along with followup of superficial spreading ... lentigos, basal cell carcinoma (especially pigmented types), squamous ...

A study reveals a high risk of skin cancer in BMT survivors, identifying key risk factors and prevention strategies.

Skin cancer often causes itching. Itching is more common with basal cell carcinoma and squamous cell carcinoma. Itching is less common with melanoma but may still be a symptom. Liver, Bile Duct, ...

The actor, 54, had a procedure done to remove basal cell carcinoma from his face and is warning his fans to take care and ...

A new pilot cohort study linked immune checkpoint inhibitors with a reduction in actinic keratoses in patients undergoing ...

Bristol Myers Squibb said it is disappointed with the outcome of a study that examined whether one of its drugs could be used to treat a certain type of skin cancer. The drug, Opdualag, didn't meet ...